The Tumor Immune Microenvironment in Pancreatic Ductal Adenocarcinoma: Neither Hot nor Cold
Pancreatic ductal adenocarcinoma (PDAC) is the most common pancreatic tumor and is associated with poor prognosis and treatment response. The tumor microenvironment (TME) is recognized as an important factor in metastatic progression across cancers. Despite extensive study of the TME in PDAC, the ce...
Main Authors: | Samuel J. S. Rubin, Raoul S. Sojwal, John Gubatan, Stephan Rogalla |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-08-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/17/4236 |
Similar Items
-
Neural Component of the Tumor Microenvironment in Pancreatic Ductal Adenocarcinoma
by: Michał Gola, et al.
Published: (2022-10-01) -
Targeted drug delivery systems for pancreatic ductal adenocarcinoma: overcoming tumor microenvironment challenges with CAF-specific nanoparticles
by: Xinming Su, et al.
Published: (2023-12-01) -
Tumor immune microenvironment-based therapies in pancreatic ductal adenocarcinoma: time to update the concept
by: Wenyu Luo, et al.
Published: (2024-01-01) -
Multiphasic Heterogeneity of Fibroblasts in the Microenvironment of Pancreatic Ductal Adenocarcinoma: Dissection and the Sum of the Dynamics
by: Hideaki Ijichi
Published: (2022-10-01) -
The coagulation-related genes for prognosis and tumor microenvironment in pancreatic ductal adenocarcinoma
by: Di Wang, et al.
Published: (2023-06-01)